Cargando…

Hair cortisol as a risk marker for increased depressive symptoms among older adults during the COVID-19 pandemic

Determining pre-existing biological risk markers of incident depression and other mental health sequelae after exposure to a new stressor would help identify vulnerable individuals and mechanistic pathways. This study investigated primarily whether hair cortisol predicted elevated depressive symptom...

Descripción completa

Detalles Bibliográficos
Autores principales: Feeney, J., Kenny, R.A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier Ltd. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9221173/
https://www.ncbi.nlm.nih.gov/pubmed/35779340
http://dx.doi.org/10.1016/j.psyneuen.2022.105847
_version_ 1784732555436621824
author Feeney, J.
Kenny, R.A.
author_facet Feeney, J.
Kenny, R.A.
author_sort Feeney, J.
collection PubMed
description Determining pre-existing biological risk markers of incident depression and other mental health sequelae after exposure to a new stressor would help identify vulnerable individuals and mechanistic pathways. This study investigated primarily whether hair cortisol predicted elevated depressive symptoms in middle-aged and older adults during the COVID-19 pandemic, 6 years later. A secondary aim was to deduce whether any association differed by sex. METHODS: We studied 1025 adults aged 50 and older (75% female) as part of The Irish Longitudinal Study on Ageing. Hair cortisol samples were collected at 2014 (Wave 3) and depressive symptoms were assessed using the 8-item Center for Epidemiological Studies Depression Scale in 2014 (Wave 3), 2016 (Wave 4), 2018 (Wave 5) and again in 2020 as part of TILDA's COVID-19 Study. Hierarchical mixed effects logistic regression models were applied to investigate the association between cortisol levels and clinically significant depressive symptoms before and during the COVID-19 pandemic. RESULTS: In a full covariate adjusted model there was a significant interaction between cortisol and wave on depressive symptoms (χ2 = 8.5, p = .03). Cortisol was positively and significantly associated with elevated depressive symptoms during the COVID-19 Study (OR =1.3, 95% CI 1.11, 1.56, p = .003), and was associated with an increased likelihood of reporting clinically significant depressive symptoms during first year of the COVID-19 pandemic, when compared with before, OR = 1.4, 95% CI 1.05, 1.9, p = .015. There was no evidence of effect modification by sex. CONCLUSIONS: Higher hair cortisol, assessed 6 years previously, predicted clinically significant depressive symptoms among middle-aged and older adults during (but not before) the pandemic. Findings suggest a biological phenotype which denotes increased susceptibility to the negative impact of environmental stress on psychological health.
format Online
Article
Text
id pubmed-9221173
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher The Author(s). Published by Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-92211732022-06-24 Hair cortisol as a risk marker for increased depressive symptoms among older adults during the COVID-19 pandemic Feeney, J. Kenny, R.A. Psychoneuroendocrinology Article Determining pre-existing biological risk markers of incident depression and other mental health sequelae after exposure to a new stressor would help identify vulnerable individuals and mechanistic pathways. This study investigated primarily whether hair cortisol predicted elevated depressive symptoms in middle-aged and older adults during the COVID-19 pandemic, 6 years later. A secondary aim was to deduce whether any association differed by sex. METHODS: We studied 1025 adults aged 50 and older (75% female) as part of The Irish Longitudinal Study on Ageing. Hair cortisol samples were collected at 2014 (Wave 3) and depressive symptoms were assessed using the 8-item Center for Epidemiological Studies Depression Scale in 2014 (Wave 3), 2016 (Wave 4), 2018 (Wave 5) and again in 2020 as part of TILDA's COVID-19 Study. Hierarchical mixed effects logistic regression models were applied to investigate the association between cortisol levels and clinically significant depressive symptoms before and during the COVID-19 pandemic. RESULTS: In a full covariate adjusted model there was a significant interaction between cortisol and wave on depressive symptoms (χ2 = 8.5, p = .03). Cortisol was positively and significantly associated with elevated depressive symptoms during the COVID-19 Study (OR =1.3, 95% CI 1.11, 1.56, p = .003), and was associated with an increased likelihood of reporting clinically significant depressive symptoms during first year of the COVID-19 pandemic, when compared with before, OR = 1.4, 95% CI 1.05, 1.9, p = .015. There was no evidence of effect modification by sex. CONCLUSIONS: Higher hair cortisol, assessed 6 years previously, predicted clinically significant depressive symptoms among middle-aged and older adults during (but not before) the pandemic. Findings suggest a biological phenotype which denotes increased susceptibility to the negative impact of environmental stress on psychological health. The Author(s). Published by Elsevier Ltd. 2022-09 2022-06-22 /pmc/articles/PMC9221173/ /pubmed/35779340 http://dx.doi.org/10.1016/j.psyneuen.2022.105847 Text en © 2022 The Authors Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Feeney, J.
Kenny, R.A.
Hair cortisol as a risk marker for increased depressive symptoms among older adults during the COVID-19 pandemic
title Hair cortisol as a risk marker for increased depressive symptoms among older adults during the COVID-19 pandemic
title_full Hair cortisol as a risk marker for increased depressive symptoms among older adults during the COVID-19 pandemic
title_fullStr Hair cortisol as a risk marker for increased depressive symptoms among older adults during the COVID-19 pandemic
title_full_unstemmed Hair cortisol as a risk marker for increased depressive symptoms among older adults during the COVID-19 pandemic
title_short Hair cortisol as a risk marker for increased depressive symptoms among older adults during the COVID-19 pandemic
title_sort hair cortisol as a risk marker for increased depressive symptoms among older adults during the covid-19 pandemic
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9221173/
https://www.ncbi.nlm.nih.gov/pubmed/35779340
http://dx.doi.org/10.1016/j.psyneuen.2022.105847
work_keys_str_mv AT feeneyj haircortisolasariskmarkerforincreaseddepressivesymptomsamongolderadultsduringthecovid19pandemic
AT kennyra haircortisolasariskmarkerforincreaseddepressivesymptomsamongolderadultsduringthecovid19pandemic